24 abril 2015
Children with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and joint damage. A new, extended therapy combines recombinant factor VIII with a fusion protein that allows the molecule to remain in the circulation longer — translating into a need for less frequent treatment.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/JI4HoCo_pJg/150424141755.htm
